ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Heart transplant patients"

  • 2018 American Transplant Congress

    Congestive Hepatic Fibrosis: Correlation with Cardiac Hemodynamics and Changes after VAD or Cardiac Transplant

    S. Dhingra,1 A. Segura,3 N. Cortes-Santiago,1 M. Schwartz,5 S. Mittal,4 P. Jalal,2 G. Sood.2

    1Pathology and Immunology, Baylor College of Medicine, Houston, TX; 2Surgery, Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX; 3Cardiovasular Pathology, Texas Heart Institute, Houston, TX; 4Gastroenterology, Kelsey Seybold Clinic, Houston, TX; 5Pathology, Houston Methodist Hospital, Houston, TX.

    Background: Chronic heart failure causes chronic passive congestion of liver that can progress to advanced fibrosis. Liver biopsy is performed for assessment of fibrosis to…
  • 2018 American Transplant Congress

    Financial Impact of Testing Standardization for Solid Organ Transplant Recipients

    S. Ugolini,2 L. Dranow,1 P. Sadler,2 M. Berry,2 J. Stehlik,1 S. Drakos,1 J. Nativi,1 E. Gilbert,1 S. McKeller,1 A. Koliopoulou,1 M. Yin,1 E. Davis,2 C. Selzman,1 O. Wever-Pinzon.1

    1Division of Cardiology, University of Utah Health, Salt Lake City, UT; 2Transplant Service Line, University of Utah Health, Salt Lake City, UT.

    Background: Infection and bone marrow suppression surveillance is common practice in transplant recipients. Ordering of inappropriate lab tests can lead to repetitive blood draws, higher…
  • 2018 American Transplant Congress

    Renal-Sparing Protocol May Be Harmful If Performed Early Post-Heart Transplant

    J. Patel, M. Johl, E. Kransdorf, M. Kittleson, S. Dimbil, R. Levine, D. Chang, L. Czer, J. Kobashigawa.

    Cedars Sinai Medical Center, Los Angeles, CA.

    Purpose: Calcineurin inhibitors (CNIs) are associated with nephrotoxicity. Renal sparing protocol (RSP) with CNI free regimen using mycophenolate and a proliferation signal inhibitor may improve…
  • 2018 American Transplant Congress

    Liver Biopsy Fibrosis Not Liver Imaging Predicts Survival after Heart Transplant

    J. Patel, M. Kittleson, E. Kransdorf, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.

    Cedars Sinai Medical Center, Los Angeles.

    Purpose: Hepatic dysfunction is common in patients with cardiomyopathy being evaluated for heart transplant (HT). ISHLT guidelines highlight the need for liver evaluation in patients…
  • 2018 American Transplant Congress

    Less Induction Therapy Means Fewer Early Readmissions with No Change in Rejection or Infection

    S. Kush, K. Boyle, J. Gray, S. Rega, I. Feurer, A. Shah, J. Lindenfeld.

    Vanderbilt University Medical Center, Nashville, TN.

    PURPOSE:In heart transplant, induction may allow for delay of calcineurin inhibitor initiation and renal recovery. Literature comparing lymphocyte-depleting and non-depleting induction conflicts in rejection rate…
  • 2018 American Transplant Congress

    Complex Combined Thoracic/liver Transplant: A Seven Year Experience

    N. Presser, J. DiNorcia, V. Agopian, H. Yersiz, D. Farmer, R. Busuttil, F. Kaldas.

    Liver and Pancreas Transplant, UCLA, Los Angeles, CA.

    Background: While rare, combined Thoracic/Liver transplants are employed with increasing frequency. Consistent data regarding the technical conduct, patient selection and outcomes in this highly complex…
  • 2018 American Transplant Congress

    Amiodarone Use Increases Morbidity Not Mortality in Pediatric Heart Transplant Recipients

    S. Amdani, A. Dalal, K. Simpson, J. Scheel, A. Abarbanell, P. Eghtesady, C. Canter, C. Castleberry.

    Pediatric Cardiology, St.Louis Children's Hospital, St. Louis, MO.

    Background: Amiodarone is commonly used in pediatric and adult patients with end-stage heart failure and its use is associated with increased 1-year post-transplant mortality in…
  • 2018 American Transplant Congress

    Extracorporeal Membrane Oxygenation Experience for Graft Failure after Heart Transplantation

    S. Lehmann, K. Jawad, S. Feder, A. Meyer, M. Dieterlen, J. Fischer, J. Garbade, M. Borger.

    Cardiac Surgery, Heart Center Leipzig, Leipzig, Germany.

    INTRODUCTION:Acute graft failure is the leading cause of early mortality after heart transplantation (HTX). Extracorporeal membrane oxygenation (ECMO) is a therapy option to treat heart…
  • 2018 American Transplant Congress

    Disparate Candidate Selection Practices and Substantial Use of Low KDPI Kidneys in Combined Heart-Kidney and Liver-Kidney Transplantation, 2012-2016

    R. Steiner,1 J. Halldorson.2

    1Transplant Nephrology, University of California at San Diego School of Medicine, San Diego, CA; 2Transplant Surgery, Sharp Memorial Hospital/Balboa Nephrology, San Diego, CA.

    Transplant professionals have struggled to formulate defensible standards for combined heart-kidney and liver-kidney transplantation (HKTs and LKTs). In these recipients, recovery of native renal function…
  • 2018 American Transplant Congress

    The Combination of pAMR and Circulating Donor-Specific Antibodies is Even More Associated with Cardiac Allograft Vasculopathy after Heart Transplant

    J. Patel, M. Kittleson, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa.

    Cedars Sinai Medical Center, Los Angeles.

    Purpose: Several reports have correlated the development of donor-specific antibody (DSA) to the development of cardiac allograft vasculopathy (CAV) after heart transplantation (HTx). Interestingly, patients…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 30
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences